LifeStance Health Group, Inc. (LFST) Stock Overview
Explore LifeStance Health Group, Inc.’s financial performance, market position, analyst ratings, and future outlook.
LifeStance Health Group, Inc. (LFST)
Key Financials
Key Financials
Market Cap
3B
P/E Ratio
129.80
EPS (TTM)
$0.06
ROE
0.02%
LFST Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of LifeStance Health Group, Inc. (LFST) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 55.08, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.16.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 129.80 and a market capitalization of 3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.